We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alpha Strategic | LSE:APS | London | Ordinary Share | GB00B0CZZR45 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 24.50 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 24.50 | GBX |
Alpha Strategic (APS) Share Charts1 Year Alpha Strategic Chart |
|
1 Month Alpha Strategic Chart |
Intraday Alpha Strategic Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/9/2013 | 13:49 | Alpha Strategic | 21 |
| 27/12/2006 | 23:11 | APS - new to AIM 11th Aug 2005 | 10 |
| 04/1/2005 | 01:19 | Ascribe.......... new to AIM | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 13/4/2011 14:24 by rambutan2 Massively illiquid and any buys will jump it up. Worth remembering that everyone ie board, Winton and IKOS payed/were payed at way above current price. So either they've written off the money or they expect to gain in a big way by Bertarelli diluting them down. |
Posted at 12/4/2011 14:32 by rambutan2 Interesting rns - big dilution but new owners are big league. Effectively rebased for a new start?Alpha Strategic plc, the AIM listed hedge fund investment group, is pleased to announce that it has conditionally raised approximately GBP2,493,722.61 (before expenses) by way of a placing (the "Placing") to Northill Europe Holdings SARL ("Northill") of 4,705,137 ordinary shares of 1 pence each (the "Ordinary Shares") in the capital of Alpha Strategic (the "Placing Shares") at a price of 53.0 pence per Ordinary Share (the "Placing Price"). Northill is a private company incorporated in Luxembourg whose sole shareholder is Northill Jersey Holdings L.P. The ultimate majority owner of Northill is the Bertarelli family. This investment by Northill represents a significant step forward for Alpha Strategic, which specialises in acquiring multiple revenue streams from a diverse range of key alternative investment strategies, managed by experienced hedge fund managers. Alpha Strategic has existing agreements with Winton Capital Management Limited and IKOS Asset Management Limited. The additional funds from Northill will be used to support and accelerate Alpha Strategic's strategy of acquiring additional, non-correlated revenue streams, which will in turn serve to expand and diversify Alpha Strategic's income base. The directors of Alpha Strategic continue to actively market Alpha Strategic's business model and discussions are, both early stage and advanced stage are ongoing... |
Posted at 11/9/2007 16:14 by boxwellian "Winton Advisors Limited is entitled to 50% of the management and incentive feesgenerated from The ESA Global Futures Fund in exchange for certain advisory services. This equates to approximately 0.5% of funds under management and 10% of profits, subject to a number of performance conditions." On $40m thats £100,000pa contribution to Admin expenses of £475,000. Hopefully growing to £250,000pa before anything from the profit share part. |
Posted at 14/6/2007 10:58 by rambutan2 slowly does it...Alpha Strategic plc ("Alpha Strategic" or the "Company") Audited Preliminary Results for the year to 31 March 2007 Financial Highlights *First acquisition, of Winton Advisors, completed. *First income received. *Global Futures Fund grows over 300% to over $41m. *Net assets up 6%. *Loss per share halved, significant progress towards profitability. *Healthy cash balance maintained at #2.3 million. Colin Barrow, Chairman of the Company, commented: " Alpha has made a good start. Our first transaction is of undisputed quality, and a firm foundation for the future. " |
Posted at 08/1/2007 13:08 by rambutan2 as far as i can see, they topped up at 125p (100k k trade), with the seller/s (2x50k) getting 118p...8 January 2007 Alpha Strategic Plc ("Alpha Strategic" or "the Company") Holdings in Company Alpha Strategic was notified today that following the purchase of 100,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") on 19 December 2006, Auvergne & Bourgogne have an interest in 300,000 Ordinary Shares representing approximately 9.07 per cent. of the issued ordinary share capital. |
Posted at 27/12/2006 23:11 by rambutan2 this lot (see post 8) have doubled up at between 118-125p. i wonder who's been selling? Alpha Strategic was notified on 22 December 2006 that following the purchase of 100,000 ordinary shares of 1 pence each in the Company ('Ordinary Shares') on 14 December 2006, Auvergne & Bourgogne have an interest in 200,000 Ordinary Shares representing approximately 6.04 per cent. of the issued ordinary share capital. |
Posted at 15/12/2006 08:43 by rambutan2 Interim Results for the 6 months ended 30th September 2006Financial Highlights * First acquisition of Winton Advisors completed. * First income received. * Strong growth in funds under management up 300% since acquisition. * Net assets up 8%. * Loss per share held at previous low levels. * Healthy cash balance maintained at #2.4 million. * Forecast to turn cash generative in first half 2007. To obtain a copy of this report, and for comprehensive information on the Company and its directors, please visit our website at: www.alphastrategic.c Chairman's Statement The past six months have been an exciting time for the Company. Our first acquisition took longer than many expected, but this was a result of our stated aim of partnering only with managers of the very highest quality. Alpha's objective is to achieve a blend of income from managers using different strategies, but it is a prerequisite that they are first class at what they do. We completed our first transaction with Winton Capital Management Limited in May through the acquisition of Winton Advisors Limited. This has provided us with a strong foundation for future transactions. These accounts show the first fruits of that acquisition Fee income has now started to flow from the Global Futures Fund and we believe it will grow rapidly over the coming months. We continue to await approval from the regulators for more public distribution of the fund in Switzerland. However, I note that despite the current limits on marketing, assets in the fund have grown from $11.5 million to over $34 million since we completed the transaction. Additionally the manager has shown solid performance during the period and we believe it is likely we should receive more incentive fees in the second half. We continue to pursue a number of promising conversations with other high quality hedge fund managers. The Company has successfully contained costs during the period and has maximized its income from our healthy cash balances. There has been much talk about M&A in the industry over the last year, however few transactions have materialised, and even fewer involving public companies. Alpha has a unique business model that has been carefully designed to address issues for hedge fund managers while building stable revenue for shareholders. We have been very encouraged by our progress in the last six months. With the growth in funds under management combined with continuing performance levels from Winton, we anticipate being able to report that we have become cash generative in the first half of 2007. Colin Barrow, Chairman. 14th December 2006 |
Posted at 09/10/2006 09:40 by rambutan2 so, perhaps that at least part of the recent rise. for the record, they bought them at 110p ie right on the offer, on 27/09/06. there was a 95k deal at 109p on same day, so perhaps that the seller, although bid price was 105p...Alpha Strategic was notified on 6 October 2006, that following the purchase of 100,000 ordinary shares of 1 pence each in the Company ('Ordinary Shares') on 27 September 2006, Auvergne & Bourgogne have an interest in 100,000 Ordinary Shares representing approximately 3.02 per cent. of the issued ordinary share capital. haven't a clue who it/they are though. |
Posted at 20/12/2004 09:44 by currypasty LSE changed ticker after 1 day tradingAscribe, the health IT group focusing on medicines management, today announces the commencement of dealings of its Ordinary Shares on the AIM market (AIM) of the London Stock Exchange. Seymour Pierce is acting as Nominated Adviser and as Broker to the Company. The stock market EPIC will be ASP.L. Placing Statistics Total number of New Ordinary Shares being placed on behalf of the Company 27,777,778 Number of Sale Shares being placed on behalf of Selling Shareholders 2,777,778 Total number of Ordinary Shares being placed 30,555,556 Issue Price 18p Number of Ordinary Shares in issue immediately following Admission 103,441,732 Percentage of the Enlarged Share Capital being placed 29.5% Market capitalisation at the Issue Price #18.6 million Gross proceeds of the Placing receivable by the Company #5 million Reasons for Admission to AIM and use of proceeds of the Placing The proceeds of the Placing of the New Ordinary Shares, expected to amount to #5 million (before expenses) will be used by the Company, amongst other things, to fund the acquisition of Protechnic Exeter Limited. Stephen Critchlow, Chairman and Chief Executive of Ascribe, said: "We are delighted that the flotation of the Company has been completed successfully. The listing will enable us to take Ascribe to the next stage of its development and maximise any acquisition opportunities for the Company within the international healthcare market. Our strategy is to build on our position in the medicines management market through organic growth and through a number of acquisitions of profitable companies, such as Protechnic Exeter, which offer complementary established systems to customers needing a medicines management solution." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
